• Home
  • >
  • Camlin Fine Sciences Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/camlin-fine-sciences-ltd.png Logo

Camlin Fine Sciences Ltd Financial Statement

Camlin Fine Sciences Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue225.88187.73211.85
Operating Expense247.91179.72184.86
Net Profit-44.07-11.64-1.46
Net Profit Margin-19.51-6.2-0.69
Earning Per Share-2.65-0.7-0.09
EBIDTA-18.0412.7326.25
Effective Tax Rate2.86-16.60.74

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Camlin Fine Sciences Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual1,681.561,412.091,187.1
Operating Expenses Annual1,476.291,259.281,005.17
Operating Profit Annual201.39185.71186.92
Interest Annual58.535.7737.53
Depreciation5245.9434.28
Net Profit Annual52.1160.6850.96
Tax Annual40.5733.6139.74

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Camlin Fine Sciences Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning107.8175.5252.37
Cash Flow from Operations50.9145.45117.38
Cash Flow from Investing-124.63-249.13-132.86
Cash Flow from Financing59.66135.9738.63
Cash Flow at the End93.74107.8175.52

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Camlin Fine Sciences Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)12.8913.5116.16
PBIT Margin (%)9.189.5412.43
PBT Margin (%)8.889.0611.85
Net PROFIT Margin (%)6.023.771.38
Return On Networth / Equity (%)6.289.9913.81
Return On Networth /Employed(%)10.6511.0814.46
Return On Assets (%)6.633.961.45
Total Debt / Equity(X)0.870.790.85
Asset Turnover Ratio (%)1.11.051.05

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Camlin Fine Sciences Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual859.8601.53581.59
Total Current Assets Annual1,087.82893.54794.69
Non Current Assets Annual972.28906.54686.91
Total Shareholders Funds Annual819.37747.93643.4
Total Assets Annual2,060.11,800.081,481.6

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Camlin Fine Sciences Ltd Earning Calls
Mar 2024
EPS beaten by 0.65 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Camlin Fine Sciences Ltd has a market capitalization of 1,494.63 Cr. Value Research classifies it as a Small-Cap company.

No, Camlin Fine Sciences Ltd is not debt-free with a debt-to-equity ratio of 0.79.

In FY 2023, Camlin Fine Sciences Ltd recorded a total revenue of approximately 1,613.06 Cr marking a significant milestone in the company's financial performance.

Camlin Fine Sciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.2% and 0.1% annually, respectively..

Camlin Fine Sciences Ltd's current PE ratio is -16.11.

Camlin Fine Sciences Ltd's ROCE averaged 6.3% from the FY ending March 2022 to 2024, with a median of 9.2%. It peaked at 9.2% in March 2023, reflecting strong capital efficiency over the period..

Camlin Fine Sciences Ltd's latest EBIT is Rs. -38.94 Cr, surpassing the average EBIT of Rs. 76.56 Cr over the 5 years..